Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
| Price | $10.80 |
|---|---|
| Market cap | $265.49M |
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NASDAQ |
| 52-week range | 10.44-11.37 |
| Beta | -0.04 |
Explore OACC's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.